- Pfizer/BioNTech, Moderna expect data on shot's protection against new COVID-19 variant soon Reuters
- Omicron COVID-19 variant: Pfizer, BioNTech say vaccine could be reworked in 100 days to counter strain Fox Business
- Merck says its Covid antiviral treatment less effective than first thought Financial Times
- With the Virus Still in Charge, Pfizer Can Be Flexible: Here's My Plan RealMoney
- Vaccine makers move quickly against new omicron Covid variant, testing already under way CNBC
- View Full Coverage on Google News
by via Top stories - Google News
No comments:
Post a Comment